Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 9 |
GO:0110165 | cellular anatomical entity | 1 | 9 |
Related structures:
AlphaFold database: Q4QFD8
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 130 | 132 | PF00675 | 0.389 |
CLV_NRD_NRD_1 | 15 | 17 | PF00675 | 0.521 |
CLV_NRD_NRD_1 | 85 | 87 | PF00675 | 0.678 |
CLV_PCSK_KEX2_1 | 130 | 132 | PF00082 | 0.407 |
CLV_PCSK_KEX2_1 | 15 | 17 | PF00082 | 0.521 |
CLV_PCSK_KEX2_1 | 85 | 87 | PF00082 | 0.656 |
CLV_PCSK_PC7_1 | 126 | 132 | PF00082 | 0.413 |
CLV_PCSK_SKI1_1 | 131 | 135 | PF00082 | 0.419 |
CLV_PCSK_SKI1_1 | 86 | 90 | PF00082 | 0.598 |
DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.797 |
DOC_MAPK_DCC_7 | 60 | 70 | PF00069 | 0.536 |
DOC_MAPK_RevD_3 | 72 | 86 | PF00069 | 0.410 |
DOC_PP2B_PxIxI_1 | 65 | 71 | PF00149 | 0.402 |
DOC_WW_Pin1_4 | 36 | 41 | PF00397 | 0.732 |
DOC_WW_Pin1_4 | 90 | 95 | PF00397 | 0.327 |
LIG_14-3-3_CanoR_1 | 130 | 139 | PF00244 | 0.669 |
LIG_14-3-3_CanoR_1 | 85 | 95 | PF00244 | 0.478 |
LIG_FHA_1 | 100 | 106 | PF00498 | 0.353 |
LIG_FHA_1 | 132 | 138 | PF00498 | 0.610 |
LIG_FHA_1 | 87 | 93 | PF00498 | 0.477 |
LIG_LIR_Gen_1 | 75 | 83 | PF02991 | 0.355 |
LIG_PCNA_PIPBox_1 | 48 | 57 | PF02747 | 0.654 |
LIG_SH2_STAT5 | 54 | 57 | PF00017 | 0.599 |
LIG_SH3_2 | 5 | 10 | PF14604 | 0.647 |
LIG_SH3_3 | 17 | 23 | PF00018 | 0.617 |
LIG_SH3_3 | 2 | 8 | PF00018 | 0.658 |
LIG_SH3_3 | 31 | 37 | PF00018 | 0.696 |
LIG_SxIP_EBH_1 | 60 | 71 | PF03271 | 0.479 |
LIG_TRAF2_1 | 24 | 27 | PF00917 | 0.677 |
MOD_CK1_1 | 132 | 138 | PF00069 | 0.670 |
MOD_CK2_1 | 21 | 27 | PF00069 | 0.671 |
MOD_GlcNHglycan | 2 | 5 | PF01048 | 0.436 |
MOD_GSK3_1 | 86 | 93 | PF00069 | 0.435 |
MOD_NEK2_1 | 46 | 51 | PF00069 | 0.531 |
MOD_NEK2_1 | 72 | 77 | PF00069 | 0.393 |
MOD_NEK2_1 | 88 | 93 | PF00069 | 0.395 |
MOD_PIKK_1 | 111 | 117 | PF00454 | 0.493 |
MOD_PIKK_1 | 22 | 28 | PF00454 | 0.674 |
MOD_PIKK_1 | 46 | 52 | PF00454 | 0.715 |
MOD_PIKK_1 | 60 | 66 | PF00454 | 0.466 |
MOD_PKA_2 | 129 | 135 | PF00069 | 0.648 |
MOD_Plk_1 | 46 | 52 | PF00069 | 0.687 |
MOD_Plk_4 | 54 | 60 | PF00069 | 0.627 |
MOD_Plk_4 | 72 | 78 | PF00069 | 0.214 |
MOD_ProDKin_1 | 36 | 42 | PF00069 | 0.731 |
MOD_ProDKin_1 | 90 | 96 | PF00069 | 0.327 |
TRG_ENDOCYTIC_2 | 78 | 81 | PF00928 | 0.377 |
TRG_Pf-PMV_PEXEL_1 | 107 | 111 | PF00026 | 0.396 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PAK1 | Leptomonas seymouri | 71% | 100% |
A0A0S4JX73 | Bodo saltans | 39% | 100% |
A0A1X0NVE4 | Trypanosomatidae | 45% | 100% |
A0A3R7RL81 | Trypanosoma rangeli | 45% | 90% |
A0A3S7WTD5 | Leishmania donovani | 90% | 100% |
A4H814 | Leishmania braziliensis | 78% | 100% |
A4HWE4 | Leishmania infantum | 91% | 100% |
C9ZNY5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 38% | 100% |
E9AQ44 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 84% | 100% |